Burp - SVNT question: I went long after the stock dropped from $22 to $12.51, when I bought. Should this be a hold just in case another buyout deal comes up, while in the alternative it'll probably keep drifting down til December sales kick in? Should I assume no downside risk if I am patient enough and is the upside even if they go it alone worth hanging on at a cost basis of $12.51? Unpredictable waiting periods of "dead money" is why I usually avoid pharma plays that hinge on certain drugs, except that I thought the FDA approval status of Krytexxa would make this a safe bet with no downside risk if I hold a while.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.